Publication | Closed Access
Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumors
30
Citations
16
References
2021
Year
Ly3295668 ErbumineMedicinePharmacologyAnti-cancer AgentCancer TreatmentOncologyCell BiologyPhase 1Monotherapy Safety Study
| Year | Citations | |
|---|---|---|
Page 1
Page 1